Menu
Not yet recruiting NCT06779591

Implementation and Effectiveness of "CareAide® App" for People with Cardiometabolic Diseases At a Primary Care Clinic

No phase Interventional Hypertension Diabetes Mellitus Type 2 Dyslipidemia

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: CareAide® Medication Adherence Mobile Application.
Who it may be relevant to
Registry conditions: Hypertension, Diabetes Mellitus Type 2, Dyslipidemia. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Malaysia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Implementation and Effectiveness of the Medication Adherence "CareAide® App" for People with Cardiometabolic Diseases At an Academic Primary Care Clinic in Malaysia: a Hybrid Implementation-effectiveness Study

Overview

This study aims to explore the barriers and facilitators to implement CareAide® app among healthcare providers and patients at a primary care clinic in Malaysia. This is an implementation-qualitative research study meaning researchers will collect data regarding the adoption rate, ease of implementation and adoption, and patient's willingness to use the application. The researchers will also compare the effectiveness of the application as a tool to remind patients to take their medicine, by comparing between a group of participants who use the app and another group of participants who do not use the app. This study requires participants to use an app, then attend some routine follow-ups and be administered blood tests, followed by an interview to collect their opinions, feelings, and experiences.

Interventions

  • Other CareAide® Medication Adherence Mobile Application
    CareAide® app is one of the mobile apps in assisting and improving patients' adherence to medications. It is an unique health-tech and insure-tech company with expertise in behavioural science, chronic condition management and technology. The app aims to help patients with chronic conditions live a better everyday life and empower their families and the ecosystem around the patients to drive better outcomes. They have the clinically validated approach to improving adherence. Using behavioural sc

Primary outcome measures

  • Reach [Time frame: Before the start of intervention]
  • Effectiveness [Time frame: Before the start of the intervention, and at 24 weeks after the intervention]
  • Effectiveness [Time frame: Before the start of the intervention, and at 24 weeks after the intervention]
  • Effectiveness [Time frame: Before the start of the intervention, and at 24 weeks after the intervention]
  • Effectiveness [Time frame: Before the start of the intervention, and at 24 weeks after the intervention]
  • Adoption [Time frame: Through study completion, an average of 1 year]
  • Implementation [Time frame: At three months and at 24 weeks after the intervention]
  • Maintenance [Time frame: Through study completion, an average of 1 year]

Eligibility criteria

Inclusion criteria

  • Above 18 years old
  • Medically diagnosed with either hypertension, type 2 diabetes and dyslipidemia for at least 6 months as listed in electronic health records
  • Exhibit a low adherence indicated by Malaysia Medication Adherence Assessment Tool (MyMAAT) scores of <54 scores
  • Taking at least one type of medication daily, three medications daily or two medications with multiple dosing intervals prescribed,
  • Owns and able to use a smartphone
  • Able to read English or Malay

Exclusion criteria

  • Individuals who are pregnant, already using any adherence apps or diagnosed with any terminal illnesses, visually impaired, disability or mental health related illnesses

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Prevention

Study locations

Malaysia · 1 center
  • Universiti Malaya Medical Centre — Petaling Jaya

Identifiers

NCT: NCT06779591 · 2024724-13968 · 2024724-13968

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗